Serum biomarkers predictive of pre-eclampsia.
Swati Anand, Tanielle Mei Bench Alvarez, W Evan Johnson, M Sean Esplin, Karen Merrell, T Flint Porter, Steven W Graves
Index: Biomark. Med. 9 , 563-75, (2015)
Full Text: HTML
Abstract
We sought serum biomarkers predictive of pre-eclampsia (PE).Sera obtained at 12-14 weeks of pregnancy from 24 cases who later developed PE and 24 controls with uncomplicated pregnancies were processed and analyzed using a serum proteomic approach.Many statistically significant serum PE biomarker candidates (n > 60) were found comparing cases and controls. In addition, logistic regression analysis modeled biomarker data resulted in 14 different multimarker combinations having high detection sensitivity and specificity (AUC >0.9).Developed panels of serum biomarkers appeared effective in identifying pregnant women at 12-14 weeks gestation at risk of PE later in their pregnancy.
Related Compounds
Related Articles:
Polyoxometalates--potent and selective ecto-nucleotidase inhibitors.
2015-01-15
[Biochem. Pharmacol. 93(2) , 171-81, (2015)]
2014-10-01
[Invest. Ophthalmol. Vis. Sci. 55(10) , 6187-93, (2014)]
Characterization of lysophospholipid metabolizing enzymes in human brain.
1994-11-01
[J. Neurochem. 63 , 1839-1848, (1994)]
2008-09-01
[Biol. Reprod. 79 , 525-536, (2008)]
Metabolism and atherogenic disease association of lysophosphatidylcholine.
2010-01-01
[Atherosclerosis 208 , 10-18, (2010)]